Concepedia

Evangelos Ntougkos

EN

6

Publications

224

Citations

6

H-Index

2005

Active since

Affiliations

Alexander Fleming Biomedical Sciences Research Center(Current)

Agricultural University of Athens

Center for Research and Technology Thessaly

University of Thessaly

National and Kapodistrian University of Athens

Evangelos Ntougkos is an author at Alexander Fleming Biomedical Sciences Research Center specializing in drug development, small molecules, and drug discovery.

ORCID

Top concepts

Publications per year

2005–2018

6

Publications

6

The IgLON Family in Epithelial Ovarian Cancer: Expression Profiles and Clinicopathologic Correlates

Evangelos Ntougkos, Robert Rush, Tobias Frankenberg et al. · Clinical Cancer Research · 2005 · 64 citations

Cheminformatics-aided discovery of small-molecule Protein-Protein Interaction (PPI) dual inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL)

Georgia Melagraki, Evangelos Ntougkos, Vagelis Rinotas et al. · PLoS Computational Biology · 2017 · 63 citations · Full text

, , +20

Genomic Responses of Mouse Synovial Fibroblasts During Tumor Necrosis Factor–Driven Arthritogenesis Greatly Mimic Those in Human Rheumatoid Arthritis

Evangelos Ntougkos, Panagiotis Chouvardas, Fani Roumelioti et al. · Arthritis & Rheumatology · 2017 · 32 citations · Full text

Rationally Designed Less Toxic SPD‐304 Analogs and Preliminary Evaluation of Their TNF Inhibitory Effects

Polyxeni Alexiou, Athanasios Papakyriakou, Evangelos Ntougkos et al. · Archiv der Pharmazie · 2014 · 27 citations

In Silico Discovery of Plant-Origin Natural Product Inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL)

Georgia Melagraki, Evangelos Ntougkos, Dimitra Papadopoulou et al. · Frontiers in Pharmacology · 2018 · 23 citations · Full text

Rows per page

1–5 of 6